CVA Family Office’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
CVA Family Office's LH Position: Q2 2026 in Review
CVA Family Office reduced its Labcorp (LH) stake by 6.9% in Q2 2026, selling an estimated $2.89K and leaving 148 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #643.
CVA Family Office first reported a position in LH in Q1 2021 and has held it in 19 quarters since. The position peaked at $42.4K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- CVA Family Office held 148 shares of Labcorp worth $41.4K as of Q2 2026.
- CVA Family Office sold 11 Labcorp shares in Q2 2026, an estimated $2.89K.
- Labcorp made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #643 holding.
- CVA Family Office first reported a position in Labcorp in Q1 2021 and has held it in 19 quarters since.
- CVA Family Office's Labcorp position peaked at $42.4K in Q1 2026.
- 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.